Article Information
History
- June 23, 2016.
Article Versions
- You are currently viewing Version 1 of this article (June 23, 2016 - 11:25).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Anthony Eccleston1,
- Anthony Bentley1,
- Matthew Dyer3,
- Ann Strydom2,
- Wim Vereecken3,
- Angela George2,4 and
- Nazneen Rahman2,4
- 1DRG Abacus, Bicester, Oxfordshire, UK;
- 2Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK;
- 3AstraZeneca UK Ltd, Luton, UK;
- 4Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, UK
- Correspondence should be sent to Matthew Dyer: matthew.dyer{at}astrazeneca.com or Nazneen Rahman: rahmanlab{at}icr.ac.uk